Autoimmunity Reviews
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 9.8 | Q1 | 90.7% | 2.669 | Q1 | 97.1% |
| 2024 | 8.3 | Q1 | 91.8% | 2.844 | Q1 | 97.4% |
| 2023 | 9.2 | Q1 | 90.8% | 2.677 | Q1 | 97.3% |
| 2022 | 13.6 | Q1 | 91.7% | 2.552 | Q1 | 97.2% |
| 2021 | 17.4 | Q1 | 92.7% | 3.168 | Q1 | 98.2% |
| 2020 | — | — | 2.621 | Q1 | 97.2% | |
| 2019 | — | — | 2.281 | Q1 | 96.5% | |
| 2018 | — | — | 2.015 | Q1 | 95.1% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1873-0183
ISSN
1568-9972
country
NLcoverage
2002-2026